Avantel Ltd (AVANTEL) — Board Meeting | 18 September 2026 (3 announcements)

Avantel's board approved altering its memorandum to add medical devices, space tech, energy and AI sectors, and greenlit merging its wholly owned subsidiary Imeds Global into itself via postal ballot, subject to shareholder approval. The merger consolidates operations and eliminates duplicate functions.

Avantel Ltd announced amendments to its Memorandum and Articles of Association at a September 18, 2026 board meeting. The changes include adding new business objects related to medical devices, space technology, energy systems, and AI, as well as approving the merger of its wholly owned subsidiary Imeds Global Private Limited into the company. The merger will be executed via postal ballot without share exchange or cash consideration, preserving the parent's shareholding structure.

Avantel announced board approval to alter its Memorandum of Association by adding medical devices, space tech, energy and AI objects, and to merge its wholly owned subsidiary Imeds Global into itself via postal ballot. The merger is tax-exempt under SEBI rules as a wholly owned subsidiary consolidation, with no share exchange or cash payout. Shareholding remains unchanged post-merger.